Moreover, dose-normalized maximum serum concentration and AUC values were significantly higher in patients from Stratum II compared to those in Stratum I. Additionally, the study revealed high expression of the EGFR family and downstream signaling activation in tumor tissues, particularly in ependymomas, which demonstrated a positive response to lapatinib therapy. The gene discussed is EGFR; the disease is neoplasm.